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1. Introduction 
Clenbuterol (1, Figure 1a), as a member of the β2-agonists 
family, has extensively been (and is still) prescribed as 
bronchodilatator in asthmatic patients.
1
 In fact, this compound is 
licensed in the EU for therapeutic use in food producing species 
and approved by the US Food and Drug Administration (FDA) 
for use in horses.
2
 Its therapeutical role to combat skeletal muscle 
atrophy secondary to disuse, injury and denervation has 
intensively been investigated and is not completely clear its 
relevance in this point.
3
 
The main problem of this type of compounds is that they are 
illegally employed because of their anabolic effects on skeletal 
muscle and their lipolytic effect, on the one hand, by sportsmen 
for doping purposes, and on in the other hand, by farmers to feed 
cattle due to financial profit reasons. This has raised public health 
concern and highlights the relevance for developing efficient 
analytical methods to detect clenbuterol and similar growth 
promoting substances in low levels.
4
 For this reason, 
identification and quantification of these compounds is difficult 
and requires reliable methodologies. Immunological,
5
 
electrochemical,
5
 spectrophotometric,
6
 and mass spectrometric 
approaches have been described but those based on 
chromatography coupled to mass spectrometric detection, such as 
GC-MS
7
 or LC-MS
8
 provide an easier implementation for a 
routine basis. The accuracy and precision in the results is an 
important handicap due to matrix effects and the required time-
consuming sample preparation steps. Isotope Dilution Mass 
Spectrometry (IDMS)
9
 is regarded as an absolute measurement 
method directly traceable to the International System of units as 
it provides results with the highest metrological quality. Most of 
the procedures use deuterated
10
 compounds as internal standards, 
however, labeling with 1 mass unit (“minimal labeling”) with 
13
C 
is more efficient to avoid differences in the physicochemical 
properties between the unlabeled and labeled compounds.
11 
 
Figure 1 a) Clenbuterol. b) 13C1-Labeled DMS-clenbuterol derivative and 
two of the characteristic breaks in its MS spectrum. The symbol * refers to 
the enriched 13C position in the molecule 
 
The EU regulations require the confirmation of the presence 
of clenbuterol by gas chromatography-mass spectrometry. When 
a full scan spectrum is recorded, a minimum of four ions shall be 
present with a relative intensity of ≥10% of the base peak
12
 In the 
analysis of clenbuterol by GC-MS, several reagents have been 
employed to derivatize it into a volatile and thermally stable 
molecule. Among them, chloro(chloromethyl)-dimethylsilane
13
 
produces a dimethylsilamorpholine (DMS) derivative with five 
ions [i.e., 331 (M-CH3) and 289 (M-
t
Bu) m/z, Figure 1b] with a 
relative intensity of ≥10% of the base peak that confirms the 
presence of clenbuterol.
14 
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Due to this, it was envisaged the synthesis of a singly-
labeled clenbuterol analogue at the carbon linked to the hydroxyl 
group, since both breaks will contain the isotopic label and 
therefore will be suitable for IDMS quantification. There are few 
routes described to obtain clenbuterol,
15
 labeled analogues such 
as D9- and D3-clenbuterol,
16
 or a radiolabeled monotritiated 
derivative.
17
 In these protocols, the starting material was usually 
4-aminoacetophenone or similar compounds, that obviously 
cannot be employed as precursors of our target molecule since 
we need to introduce the mark at the carbonyl position. In our 
case, due to its easy accessibility, aniline (2) or acetanilide (3) 
was chosen as the starting material, and therefore the key-step to 
introduce the labeled carbon would be the employment of a 
Friedel-Crafts acylation protocol. 
2. Results and Discussion 
Friedel-Crafts acylation
18
 provides a useful methodology to 
achieve aromatic ketones. The usual way to perform it makes use 
of Lewis acids such as AlCl3. While with ortho- and para-
directing groups like alkyl, alkoxy, or halogen present in the 
benzene moiety, the p-acylated product is usually obtained with 
high yields, when highly deactivating or amino groups are 
present at the molecule, this reaction is more difficult to achieve. 
In fact, there are only few examples employing aniline or 
acetanilide as substrates in order to obtain the corresponding 
acetophenone derivatives. Thus, ZrO2 and acetyl chloride at 
60ºC,
19
 aluminum metal powder
20
 or zinc
21
 with acetyl chloride 
under microwave conditions, and Ga(OTf)3 with acetic anhydride 
at 50ºC
22
 have been used to perform this specific transformation. 
Unfortunately, in our hands most of these procedures did not 
work although several conditions were tried (see Supporting 
Information). 
Due to this, we decided to achieve this transformation under 
the more usual conditions with AlCl3 or FeCl3 (Table S1, 
Supporting Information). When aniline was used as substrate 
with acetyl chloride or acetic anhydride as acylating agent, N-
acylation was always achieved, therefore we tried this reaction 
with acetanilide directly. Microwave or thermal conditions were 
employed with AlCl3 and acetyl chloride
23
 in dichloromethane, 
but no or very low conversion (8%) was observed. The use of 
FeCl3 as catalyst was not efficient as well. Finally, we were glad 
to obtain a good conversion of 70% of 3 into 4 when 3.2 equiv. 
of AlCl3 and 2 equiv. of acetyl chloride were employed in 1,2-
dichloroethane at 60ºC for 24 h. When this reaction was repeated 
employing marked CH3
13
COCl to obtain 4a, the reaction yield 
was comparable. 
Once compound 4 was achieved with good yield, the next step 
was to find the suitable reaction conditions to hydrolyze the 
acetamido into the corresponding amine affording 5, since the 
following chlorination step would need the free amino group to 
activate positions 3 and 5 in order to achieve derivative 6. 
Among the different methodologies to obtain aniline derivatives 
from their acetylated counterparts,
24
 we chose the basic 
hydrolysis employing NaOH 3N in MeOH at 50ºC (Scheme 1). 
Thus, after 20 h the desired compound was obtained as the only 
product with good yield. In a subsequent experiment, the two 
first reactions were done without purification of 4, synthesizing 5 
from 3 with a combined yield of 40% after flash 
chromatography. 
 
Scheme 1 Synthesis of compound 5 starting from 4. 
 
The next step is the chlorination of the phenyl ring at positions 
3 and 5. Among all methods described in the bibliography to 
perform this transformation, it can be highlighted the use of 
NaOCl,
15a,25
 chlorine,
26
 and N-chlorosuccinimide (NCS). Due to 
its easy handling, we chose this last reagent trying to find the 
optima conditions (Table S2, Supporting Information). Thus, we 
started employing an excess of NCS with p-toluenesulfonic acid 
(p-TsOH) at different temperatures, but in all cases a mixture of 
different compounds was obtained. When employing a lower 
excess of both NCS and acid, the desired product was isolated 
with 25% yield after flash chromatography. Finally, we followed 
a procedure using NCS in HCl 2N at 45ºC.
15b
 Under these 
conditions, hydrochloride 6.HCl was obtained as a precipitate in 
the reaction medium, and therefore a simple filtration afforded 
the desired product with 75% yield. When repeating this 
sequence starting from 3 and using CH3
13
COCl, labeled 
compound 6a.HCl was achieved with similar yields (Scheme 2). 
 
Scheme 2 Obtaining of derivative 6a.HCl from acetanilide 3. 
 
The next step was the α-bromination of 6.HCl to obtain 
derivative 7 employing the typical conditions with Br2 in CH2Cl2. 
The same transformation was previously reported in 
chloroform.
27
 This reaction was very dependent concerning the 
bromine equivalents and the addition procedure. Thus, it was 
found that the best conditions were observed when adding at the 
beginning 0.6 equiv. of Br2 and later several portions of 0.2 
equiv. of bromine until the α,α-dibrominated derivative 8 was 
detected by TLC. At this point, we were able to isolate 
compound 7 with a yield of 71%, as previously shown in 
chloroform (Scheme 3).
27
 Again, this reaction afforded a 
comparable yield when marked substrate 6a.HCl was used as 
substrate. 
 
Scheme 3 Bromination of derivative 6.HCl to afford 7 and 8. 
 
To synthesize labeled clenbuterol 1a from intermediate 7a, 
two different approaches can be done (Scheme 4). This is: a) 
reduction of the ketone into the corresponding bromohydrin 9a 
and subsequent SN2 reaction with tert-butylamine; or b) 
nucleophilic substitution with 
t
BuNH2 to afford ketone 10a and 
subsequent reduction of this intermediate. 
 3 
 
Scheme 4 Pathways to obtain labeled clenbuterol 1a from 
derivative 7a. 
 
Firstly, pathway “a” (Scheme 4) was tried employing substrate 
7. Thus, reduction with NaBH4 in EtOH at 0ºC quantitatively 
afforded the desired alcohol 9 with traces of epoxide 11, but this 
should not be a problem since the SN2 reaction over both 
substrates should afford clenbuterol. Surprisingly, when this 
substitution reaction was done with 
t
BuNH2 in different solvents 
and temperatures (Table S3, Supporting Information), the 
reaction proceeded forming one product, although by 
1
H-NMR 
and MS it was discovered that this compound was not 1 but its 
regioisomer 12 (Scheme 5). This fact can be explained taking 
into account the formation of epoxide 11 as intermediate of this 
process catalyzed by the amine. The synthesis of similar 
derivatives through the corresponding epoxides has already been 
described.
28
 
 
Scheme 5 Formation of derivative 12 through epoxide 11. 
 
Due to this, we chose pathway “b” (Scheme 4) to obtain 
clenbuterol. Thus, reaction of 7 with tert-butylamine in CHCl3 at 
50ºC afforded derivative 10 after 24 h. Due to its low stability, 
the reduction process was in situ performed, after evaporation of 
the solvent and the remaining 
t
BuNH2, using NaBH4 in MeOH or 
LiAlH4 in THF at room temperature, but in both cases the final 
product could not be isolated. However, when the reduction with 
NaBH4 was kept at pH 7, the final product could be obtained as 
chlorhydrate with a combined yield of 25% for both processes. 
When these reactions were done over labeled 7a, 
13
C1-clenbuterol 
1a.HCl was achieved with comparable yield. 
3. Conclusions 
Recent analytical findings
11
 have demonstrated the utility of 
labeled compounds with a minimum number of 
13
C-atoms to 
develop new methodologies based on IDMS for the analysis of 
organic compounds. Thus, we strongly believe that demand of 
further single 
13
C-enriched compounds will significantly increase 
in the near future. Herein, we have described the first synthesis of 
the singly-labeled 
13
C1-clenbuterol derivative. The crucial step 
was the Friedel-Crafts reaction with marked acetyl chloride over 
acetanilide, and the following reactions were done under typical 
conditions with good yields. This is the first time where a 
Friedel-Crafts protocol has been applied to the synthesis of a 
clenbuterol derivative. Special mention must be done in the 
formation of the regioisomer of clenbuterol when the substitution 
reaction occurs over the epoxide and not over the bromohydrin, 
being a nice example of how although epoxides and halohydrins 
are considered as similar chemical functionalities, they can offer 
different features that can be exploited chemoselectively.
29
 
4. Experimental section 
4.1. General 
All employed reagents were purchased from commercial 
sources. Reagents and solvents were of the highest quality 
available. 4-Acetamidoacetophenone was purchased from Sigma-
Aldrich (St. Louis, MO, USA). Labeled compound 
13
C1-acetyl 
chloride (99% nominal enrichment) was obtained from Sigma-
Aldrich (St. Louis, MO, USA) in pure liquid form. Aluminum 
chloride, N-chlorosuccinimide, bromine, tert-butylamine, sodium 
borohydride and sodium hydroxide of pure grade were 
commercially supplied by Sigma-Aldrich. All solvents (hexane, 
methanol, dichloroethane, dichloromethane and chloroform) were 
obtained from Merck. 
Melting points were taken on samples in open capillary tubes 
and are uncorrected. IR spectra were recorded on an Infrared 
Fourier Transform spectrophotometer using KBr or NaCl pellets. 
Flash chromatography was performed using silica gel 60 (230-
400 mesh). 
1
H- and 
13
C-NMR spectra were measured on DPX-
300 (
1
H, 300.13 MHz and 
13
C, 75.5 MHz). Chemical shifts are 
given in delta () values, the coupling constants (J) in Hertz (Hz), 
and tetramethylsilane was used as the internal standard. ESI
+
 or 
EI
+
 was used to record mass spectra (MS) and high-resolution 
mass spectra (HRMS). Microwave employed was purchased 
from CEM Corporation, Mathews, N.C., USA. 
4.2. 
13
C1-4’-acetamidoacetophenone (4a) 
To a solution of acetanilide (0.8 mmol, 108 mg) in 1,2-
dichloroetane (2 mL), AlCl3 (2.55 mmol, 341 mg) and 
13
C1-acetyl 
chloride (1.6 mmol, 117 µL) were added under nitrogen 
atmosphere. The resulting mixture was stirred and heated at 60°C 
during 24h. The progress of the reaction was followed by TLC 
(60% ethyl acetate / hexane), and it was stopped when the 
starting material had been totally consumed. After cooling at 
room temperature, the crude was firstly extracted with 
dichloromethane (5 x 10 mL). The aqueous phase was treated 
with NaOH pellets until pH 5-6 was reached, and then it 
extracted with dichloromethane (2 x 10 mL). The organic layers 
were combined, washed with brine (2 x 10 mL), and dried over 
anhydrous Na2SO4, filtered and concentrated under reduced 
pressure to afford a crude that was purified by flash 
chromatography using mixtures of ethyl acetate / hexanes as 
eluent, affording 4a with 70% isolated yield. Solid; mp 165-169 
ºC; IR (NaCl) ν 744, 896, 1179, 1265, 1422, 1601, 1642, 2306, 
2987, 3055; 
1
H-NMR (300 MHz, d4-MeOD) 2.33 (s, 3H, Ha), 
Tetrahedron 4 
2.74 (d, 3H, H2, 
2
JCH 5.7 Hz), 7.88 (d, 2H, Hm, 
3
JHH 8.5 Hz), 
8.13 (dd, 2H, Ho, 
3
JHH 8.3 
3
JCH 3.3 Hz); 
13
C-NMR (75 MHz, d4-
MeOD) 22.6 (Ca), 25.0 (d, C2, 
1
JCC 42.4 Hz), 118.6 (d, Cm, 
3
JCC 
3.8 Hz), 129.3 (d, Co, 
2
JCC 2.8 Hz), 132.2 (d, Ci, 
1
JCC 53.2 Hz), 
142.1 (Cp), 170.5 (Cc), 198.0 (C1); MS [EI
+
, m/z (%)] 179 (6), 
178 (32), 163 (10), 136 (20), 121 (100); HRMS (ESI
+
) calcd for 
13
CC9H11NNaO2 [(M+Na)
+
] 201.0715, found 201.0715. 
4.3. 
13
C1-4’-aminoacetophenone (5a) 
To a solution of 
13
C1-4’-acetamidoacetophenone (5.75 mmol, 
1019.2 mg) in methanol (10 mL), NaOH 3N (45 mmol, 15 mL) 
was added under stirring. The mixture was heated at 50ºC for 20 
h. The progress of the reaction was followed by TLC (60% ethyl 
acetate / hexane). After cooling at room temperature, the solvent 
was removed by evaporation under reduced pressure. The crude 
material was extracted with dichloromethane (3 x 20 mL), the 
organic layers were combined, dried over anhydrous Na2SO4, 
filtered, and concentrated under reduced pressure. The residue 
was subjected to flash chromatography (silica gel) using ethyl 
acetate / hexane mixtures as eluent, affording 5a in 61% isolated 
yield. Solid, mp 103-107 ºC; IR (NaCl) ν 740, 896, 1266, 1422, 
1596, 2306, 2987, 3055, 3405; 
1
H-NMR (300 MHz, CDCl3) 
2.50 (d, 3H, H2, 
2
JCH 5.8 Hz), 6.64 (d, 2H, Hm, 
3
JHH 8.6 Hz), 
7.80 (dd, 2H, Ho, 
3
JHH 8.4 
3
JCH 3.5 Hz); 
13
C-NMR (75 MHz, 
CDCl3)  26.4 (d, C2, 
1
JCC 42.3 Hz), 114.1 (d, Cm, 
3
JCC 3.9 Hz), 
128.3 (d, Ci, 
1
JCC 55.8 Hz), 131.1 (d, Co, 
2
JCC 2.6 Hz), 151.4 (Cp), 
196.8 (C1); MS [EI
+
, m/z (%)] 137 (4), 136 (48), 121 (100), 92 
(42); HRMS calcd for 
13
CC7H9NNaO [(M+Na)
+
] 159.0615, 
found 159.0609. 
4.4. 
13
C1-4’-amino-3’,5’-dichloroacetophenone.HCl (6a.HCl) 
N-Chlorosuccinimide (3.14 mmol, 420 mg) was added into a 
solution of 5a (1.26 mmol, 170 mg) in HCl 2N (2 mL). The 
reaction was heated at 50ºC and stirred during 10 h. The progress 
of the reaction was followed by TLC (60% ethyl acetate / 
hexane), until the starting material was totally consumed. The 
formed solid was filtered, washed with water at 0°C (2 x 20 mL), 
and dried under reduced pressure to give the corresponding 
product in 75% isolated yield. Solid, mp 163-168 ºC; IR (NaCl) ν 
740, 896, 1266, 1422, 1610, 2307, 2987, 3055, 3399; 
1
H-NMR 
(300 MHz, CDCl3) 2.50 (d, 3H, H2, 
2
JCH 5.9 Hz), 4.93 (s, 2H, 
NH), 7.82 (d, 2H, Ho, 
3
JCH 3.8 Hz); 
13
C-NMR (75 MHz, CDCl3)  
25.9 (d, C2, 
1
JCC 42.9 Hz), 118.7 (d, Cm, 
3
JCC 5.7 Hz), 127.5 (d, 
Ci, 
1
JCC 54.6 Hz), 128.5 (d, Co, 
2
JCC 3.0 Hz), 144.1 (Cp), 194.4 
(C1); MS [EI
+
, m/z (%)] 208 (8), 206 (30), 204 (48), 193 (16), 
191 (64), 189 (100), 164(2), 162 (10), 160 (14), 124 (22); HRMS 
(ESI
+
) calcd for 
13
CC7H7Cl2NNaO [(M+Na)
+
] 226.983, found 
226.9832. 
4.5. 
13
C1-4'-Amino-2-bromo-3',5'-dichloroacetophenone (7a) 
To a solution of 6a.HCl (1.70 mmol, 350 mg) in 
dichloromethane (8 mL), a bromine solution [(1.02 mmol, 52 µL) 
in dichloromethane (2 mL)] was added dropwise under strong 
agitation. The progress of the reaction was followed by TLC 
every few minutes (60% hexane / dichloromethane), and when no 
progress was observed, other 0.2 equiv. of Br2 in 0.5 mL of 
CH2Cl2 were added until de formation of 2,2-dibrominated 
derivative was detected by TLC. The reaction was kept at room 
temperature and the total time was usually 2 h. The solvent was 
removed by evaporation at reduced pressure and the residue was 
subjected to flash chromatography (silica gel) using 
dichloromethane / hexane mixtures as eluent, affording 7a in 
70% isolated yield. Solid, mp 153-158 ºC; IR (NaCl) ν 739, 896, 
1076, 1265, 1421, 1488, 1583, 1619, 2306, 2987, 3054, 3394, 
3492; 
1
H-NMR (300 MHz, d4-MeOD) 4.55 (d, 2H, H2, 
2
JCH 3.4 
Hz), 7.92 (d, 2H, Ho, 
3
JCH 3.8 Hz); 
13
C-NMR (75 MHz, d4-
MeOD)  31.9 (d, C2, 
1
JCC 44.3 Hz), 119.8 (d, Cm, 
3
JCC 6.0 Hz ), 
124.7 (d, Ci, 
1
JCC 59.2 Hz), 131.0 (d, Co, 
2
JCC 3.0 Hz), 148.0 (Cp), 
190.8 (C1); MS [ESI
+
, m/z (%)] 208 (M-Br, 9); 206 (M-Br, 29); 
204 (M-Br, 46); 193 (14); 191 (64); 189 (100). 
As byproduct, 
13
C1-4’-amino-2,2-dibromo-3',5'-dichloro-
acetophenone 8a was also obtained. Solid, 
1
H-NMR (300 MHz, 
CDCl3) 5.13 (s, 2H, NH2), 6.53 (d, 1H, H2, 
2
JCH 0.7 Hz), 7.98 
(d, 2H, Ho, 
3
JCH 3.8 Hz).
 13
C-NMR (75 MHz, CDCl3)  38.9 (d, 
C2, 
1
JCC 44.1 Hz), 118.6 (d, Cm, 
3
JCC 6.2 Hz), 120.1 (d, Ci, 
1
JCC 
62.6 Hz), 129.9 (d, Co, 
2
JCC 2.8 Hz), 145.2 (Cp), 182.8 (C1); 
HRMS (ESI
+
) calcd for 
13
CC7H5Br2Cl2NNaO [(M+Na)
+
] 
382.804, found 382.8044. 
4.6. 
13
C1-1-(4´-amino-3´,5´-dichlorophenyl)-2-(tert-
butylamino)ethanone.HCl (10a.HCl) 
In a sealed tube 7a (0.52 mmol, 150 mg) was dissolved in 
anhydrous chloroform (3 mL) and then t-butylamine (8.20 mmol, 
860 µL). The solution was heated at 50ºC with agitation for 24 h. 
After this time, the solution had an intense orange color. After 
cooling to room temperature, the solvent and the excess of t-
butylamine were removed by evaporation under reduced pressure 
and the residue was extracted with chloroform (5 x 2 mL). The 
organic layers were combined, dried over anhydrous Na2SO4, 
filtered, and concentrated under reduced pressure. The solid was 
diluted in 3 mL of anhydrous chloroforme and HCl-diethylether 
was added dropwise to afford the chlorhydrate. Some drops of 
diethylether were added to improve the precipitation. The 
resulting solid was filtered, washed with diethylether (2 x 3 mL), 
and dried under reduced pressure obtaining 10a.HCl. Due to its 
instability, we subsequently proceeded with the reduction. 
4.7. 
13
C1-1-(4´-amino-3´,5´-dichlorophenyl)-2-(tert-
butylamine)ethanol.HCl or 
13
C1-clenbuterol.HCl (1a.HCl) 
To a solution of 10a.HCl (0.25 mmol, 80 mg) in water (1.5 
mL) and methanol (2 mL), NaOH 1N was added until pH 7, and 
afterwards a NaBH4 solution in water (0.05 mmol, 2 mg of 
NaBH4 in 0.5 mL of water) was added in portions. The mixture 
was stirred at room temperature and after 1 h, the mixture was 
basified with NaOH 2N until pH 10. The progress of the reaction 
was followed by TLC (50% dichloromethane / methanol) until 
the starting material was totally consumed. Methanol was 
removed by evaporation at reduced pressure. The aqueous phase 
was extracted with dichloromethane (3 x 10 mL). The organic 
layers were combined, dried over anhydrous Na2SO4, filtered and 
concentrated under reduced pressure. The solid was dissolved 
with dichloromethane (1 mL) and drops of HCl-diethylether (pH 
3-4) were added to afford the chlorhydrate. Then, 1 mL of 
diethylether was added and the product was left at −20°C to 
allow the precipitation of the final product 1a.HCl (25% yield 
from 7a). The resulting solid was filtered, washed with 
diethylether (2 x 5 mL) and dried under reduced pressure. Solid, 
mp decompose. IR (NaCl) ν 740, 896, 1265, 1421, 1626, 2306, 
2987, 3055, 3402; 
1
H-NMR (300 MHz, d4-MeOD)  1.42 (s, 9H, 
t
Bu), 2.99-3.18 (m, 2H, H2), 4.81 (ddd, 1H, H1, 
1
JCH 157.6, 
3
JHH 
13.1, 
3
JHH 3.2 Hz), 7.37 (d, 2H, Ho, 
3
JCH 4.2 Hz); 
13
C-NMR (75 
MHz, d4-MeOD)  26.4 (C4), 58.9 (d, C2, 
1
JCC 7.4 Hz), 70.2 (C1), 
80.0 (C3), 121.3 (d, Cm, 
3
JCC 5.6 Hz), 127.5 (d, Co, 
2
JCC 3.4 Hz), 
133.1 (d, Ci, 
1
JCC 48.8 Hz), and 142.4 (Cp); MS [ESI
+, 
m/z (%)] 
282 (10), 280 (63), 278 (100), 262 (15), 260 (24), 206 (19), 204 
(30); HRMS (ESI
+
) calcd for 
13
CC11H18Cl2N2O [M
+
] 278.0902, 
found 278.0900. 
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